Furthermore, propranolol, by inhibiting the expression of NF-κB, EGFR, COX, VEGF, and other factors, improves the radiotherapy effects of oxaliplatin and tigio against gastric cancer [201]. The gene discussed is VEGFA; the disease is gastric cancer.